TG Therapeutics Reports Positive Interim Data from UNITY-NHL Phase 2b Trial Evaluating Umbralisib Monotherapy in Patients with Marginal Zone Lymphoma at the 2019 AACR Annual Meeting

Drug Category : Array
Conference Category : Array
Lead Author : Fowler N, et al.
Published Date : 01/04/2019
Download Link : https://www.tgtherapeutics.com/FINAL%20TGTX%20MZL%20AACR%20ORAL%20PRESENTATION%20FOWLER%202019.pdf
Download Text : Download
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top